Beneficient (BENF) Stock Analysis — April 2026 Rating, Price, and Forecast
Company Overview — What Does Beneficient Do?
Beneficient, a technology-enabled financial service company, provides liquidity solutions to participants in the alternative asset industry. It operates AltAccess platform, which provides liquidity, custody, and investment analytics solutions, including AltLiquidity, an online tool that helps to find liquidity solutions for its alternative assets on a cybersecure platform; AltQuote, a quote tool for alternative assets; AltAccess, a secure platform for end-to-end alternative asset transactions; AltCustody to digitize and track its alternative assets; AltData, an investment analytics for its alternative asset data in one place; and AltTrading, a trading solution. The company serves mid-to-high net worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. The company is based in Dallas, Texas. Beneficient (BENF) is classified as a micro-cap stock in the Financials sector, specifically within the Banking industry. The company is led by CEO Brad K. Heppner. With a market capitalization of $47M, BENF is one of the notable companies in the Financials sector.
Beneficient (BENF) Stock Rating — Reduce (April 2026)
As of April 2026, Beneficient receives a Reduce rating with a composite score of 42.5/100 and 2 out of 5 stars from the Blank Capital Research quantitative model.BENF ranks #2,552 out of 4,446 stocks in our coverage universe. Within the Financials sector, Beneficient ranks #666 of 891 stocks, placing it in the lower half of its Financials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).
BENF Stock Price and 52-Week Range
Beneficient (BENF) currently trades at $4.02. The stock gained $0.32 (8.7%) in the most recent trading session. The 52-week high for BENF is $9.96, which means the stock is currently trading -59.6% from its annual peak. The 52-week low is $0.22, putting the stock 1737.9% above its annual trough. Recent trading volume was 12.8M shares, indicating strong institutional interest and high liquidity.
Is BENF Overvalued or Undervalued? — Valuation Analysis
Beneficient (BENF) carries a value factor score of 70/100 in the Blank Capital model, suggesting the stock trades at a meaningful discount to its fundamental earning power. The price-to-sales ratio is 7.03x, compared to 0.90x for the average Financials stock. On an enterprise value basis, BENF trades at 3.43x EV/EBITDA, versus 3.26x for the sector.
Based on these multiples, Beneficient appears attractively valued relative to both its sector peers and the broader market. Value-oriented investors may find the current entry point compelling, particularly if the company's fundamental quality metrics also score well.
Beneficient Profitability — ROE, Margins, and Quality Score
Beneficient (BENF) earns a quality factor score of 10/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -551.1%, compared to the Financials sector average of 8.5%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -34.0% versus the sector average of 1.2%.
The operating margin is -97.1% (sector: 21.8%). Net profit margin stands at -99.8%, versus 17.7% for the average Financials stock. Revenue growth is running at 118.1% on a trailing basis, compared to 9.4% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.
BENF Debt, Balance Sheet, and Financial Health
Beneficient has a debt-to-equity ratio of -199.0%, compared to the Financials sector average of 121.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 0.90x, which may signal near-term liquidity tightness. Total debt on the balance sheet is $104M. Cash and equivalents stand at $5M.
BENF has a beta of -0.22, meaning it is less volatile than the S&P 500, making it a relatively defensive holding. The stability factor score for Beneficient is 36/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.
Beneficient Revenue and Earnings History — Quarterly Trend
In TTM 2026, Beneficient reported revenue of $8M. Net income for the quarter was $-115M. Operating income came in at $-116M.
In Q3 2026, Beneficient reported revenue of $19M. Net income for the quarter was $6M. Revenue grew 322.5% year-over-year compared to Q3 2025. Operating income came in at $4M.
In Q2 2026, Beneficient reported revenue of $-3M. Net income for the quarter was $-18M. Revenue grew -132.3% year-over-year compared to Q2 2025. Operating income came in at $-18M.
In Q1 2026, Beneficient reported revenue of $-13M. Net income for the quarter was $-93M. Revenue grew -225.7% year-over-year compared to Q1 2025. Operating income came in at $-93M.
Over the past 8 quarters, Beneficient has experienced revenue contraction from $10M to $8M. Investors analyzing BENF stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.
BENF Dividend Yield and Income Analysis
Beneficient (BENF) does not currently pay a dividend. This is common among smaller companies in the Banking industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Financials dividend stocks may want to explore other Financials stocks or use the stock screener to filter by dividend yield.
BENF Momentum and Technical Analysis Profile
Beneficient (BENF) has a momentum factor score of 66/100, reflecting neutral trend characteristics. The stock is neither significantly outperforming nor underperforming the broader market on a momentum basis. The investment factor score is 21/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 69/100 reflects moderate short selling activity.
BENF vs Competitors — Financials Sector Ranking and Peer Comparison
Within the Financials sector, Beneficient (BENF) ranks #666 out of 891 stocks based on the Blank Capital composite score. This places BENF in the lower half of all Financials stocks in our coverage universe. Key competitors and sector peers include WHITE MOUNTAINS INSURANCE GROUP LTD (WTM) with a score of 62.9/100, OPPENHEIMER HOLDINGS INC (OPY) with a score of 62.6/100, Enact Holdings, Inc. (ACT) with a score of 61.6/100, International General Insurance Holdings Ltd. (IGIC) with a score of 61.3/100, and PARKE BANCORP, INC. (PKBK) with a score of 60.4/100.
Comparing BENF against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full BENF vs S&P 500 (SPY) comparison to assess how Beneficient stacks up against the broader market across all factor dimensions.
BENF Next Earnings Date
No upcoming earnings date has been announced for Beneficient (BENF) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.
Should You Buy BENF? — Investment Thesis Summary
The quantitative profile for Beneficient suggests caution. The quality score of 10/100 flags below-average profitability. The value score of 70/100 suggests attractive pricing relative to fundamentals. Price momentum is positive at 66/100, suggesting the trend favors buyers. High volatility (stability score 36/100) increases portfolio risk.
In summary, Beneficient (BENF) earns a Reduce rating with a composite score of 42.5/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on BENF stock.
Related Resources for BENF Investors
Explore more research and tools: BENF vs S&P 500 comparison, top Financials stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare BENF head-to-head with peers: BENF vs WTM, BENF vs OPY, BENF vs ACT.